BACKGROUND Oxytocin for the purposes of augmentation and induction of labour is one of the most frequently used medications in obstetrics. Recent studies show that oxytocin is used in over 50% of labouring women in some hospitals. Yet, there is tremendous variability in the dose and dosing interval in clinical practice. The objective of this study was to evaluate peri-operative usage of syntocinon for all LSCS patients to augment better uterine contractions, and for minimising peri operative morbidity and mortality. MATERIALS AND METHODS 200 patients of ASA grade I & II in the age group 20-35 years scheduled for both elective & emergency LSCS surgeries were divided randomly in two groups, Group NSI (Control) and Group SI (Test). 100 ml NS with 2 units of syntocinon was added and infusion was continued at the rate of 30 to 50 drops per minute, immediately after performing subarachnoid block in the test group. At 1 min, 2 min, 3 min, 5 min, parameters like heart rate, saturation, blood pressure, uterine tonicity and newborn APGAR score were recorded & compared with control group. RESULTS Both the groups were comparable in terms of Age & Parity. In terms of uterine tonicity, usage of vasopressor/glycopyrrolate, blood loss & perioperative HCT, the p-value is <0.00001 & results are significant in test group in comparison with control group. CONCLUSION With this study we conclude that perioperative syntocinon infusion of 2 units in 100 ml NS (before the uterine incision and delivery of the baby) as a priming technique was found to be more beneficial in maintaining haemodynamic stability, good uterine contractions, minimal uterine blood loss, without alteration in APGAR scoring is noted.